NuScale Power (SMR +5.77%) stands at a pivotal crossroads as it ventures into the small modular reactor (SMR) market, displaying the dual nature of opportunity and risk. While its status as the only SMR developer with U.S. Nuclear Regulatory Commission (NRC) approval positions it as a leader, its market performance reveals a different narrative. Over the past six months, shares plummeted by nearly 70%, reflecting growing skepticism among investors despite its first-mover advantage. Currently valued at around $4 billion, NuScale’s market cap pales in comparison to Oklo (OKLO +6.94%), another player in nuclear technology that has yet to secure NRC approval.
Weighing the Pros and Cons of Investing Today
This stark market reaction brings to light the complexities facing NuScale Power. The company’s ambitious regulatory journey culminated with the NRC approving its 77-megawatt SMR design in May 2025, following an earlier 50-MW nod. However, this regulatory success is tempered by a notable absence of revenue generation from SMR sales. Investors are confronted with the question: Can NuScale convert regulatory approval into financial success?
| Stakeholders | Pros (Before) | Cons (After) |
|---|---|---|
| NuScale | Exclusive NRC approval, established technology. | Significant stock decline, no revenue yet. |
| Investors | First-mover advantage, potential market leader. | Declining market cap, speculative nature of investment. |
| Regulators | Familiar technology, faster approval process. | Pressure to ensure safety and effectiveness of emerging tech. |
| Competitors | Market insights, potential for collaboration. | Innovation risks from novel cooling technologies. |
NuScale’s regulatory advantage stems from its adherence to established light-water reactor technology, which comprises approximately 96% of the nuclear reactors currently operational. This familiarity affords regulatory bodies a level of comfort; however, potential customers appear hesitant to commit. For instance, NuScale’s major project in Romania, set to harness six modules for a 460-megawatt output, bears an expected cost of about $7 billion. This financial burden raises eyebrows and questions about the practicality of SMR investments.
The Case Against NuScale: Where’s the Power?
While NuScale’s approach is not about reinventing the wheel, its philosophy of downsizing existing technologies raises concerns about adoption. The company’s first planned initiative, the Carbon Free Power Project (CFPP), suffered cancellation due to escalating costs. As NuScale navigates this unfavorable terrain, investors must weigh these counterpoints against its potential for exponential growth.
The market landscape is not static. Oklo is emerging as a formidable player, utilizing liquid sodium for cooling, which has yet to be commercially tested in the U.S. This divergence in technologies might at first seem disadvantageous for Oklo, but uncharted pathways can sometimes lead to revolutionary outcomes. As NuScale’s regulatory standing solidifies, the looming competition raises critical questions about its ability to sustain momentum.
Localized Ripple Effects: The Global Market Perspective
The implications of NuScale’s journey resonate beyond U.S. borders, impacting nuclear policy and investment attitudes in countries like the UK, Canada, and Australia. For instance, as the UK intensifies its commitment to nuclear energy, the reception of NuScale’s SMR technology could influence local market dynamics. Investors in Canada are also monitoring NuScale closely, as Canada is set to expand its SMR initiative to meet net-zero emissions goals. In Australia, where discussions surrounding nuclear energy are heating up, NuScale’s advancements could reshape public perceptions and regulatory frameworks.
Projected Outcomes: Three Developments to Watch
As NuScale Power finds itself at this critical juncture, the coming weeks will be telling. Here are three developments to observe:
- Customer Contracts: Watch for NuScale securing its first significant contracts which would validate its technology and business model.
- Investment Trends: Monitor shifts in investor sentiment that may emerge from performance reports and news flows, particularly concerning the competitive threats posed by Oklo.
- Regulatory Milestones: Keep tabs on any new regulatory approvals or changes that could affect NuScale’s deployment timeline, especially as it relates to international markets.
In conclusion, while NuScale holds a regulatory edge today, the survival of its speculative appeal depends on its ability to pivot strategically in an evolving nuclear landscape filled with both potential and threats.
